|
|
|
|
|
|
|
|
|
|
New breast cancer susceptibility gene
"....XRCC2 may also provide a new target for chemotherapy. "A type of drug called a PARP inhibitor appears to kill tumor cells that have gene mutations in a particular DNA repair pathway. XRCC2 is in this pathway, as are BRCA1 and BRCA2. It's reasonably likely that a breast cancer patient who has a mutation in XRCC2 will respond well to treatment with PARP inhibitors," said Tavtigian......."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.